Atlas Trials

Huda Salman

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Huda Salman

RecordFirmDate
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant (NCT06197672)Huda Salman2024-03-19
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML. (NCT06071624)Huda Salman2024-02-21
CD4CAR for CD4+ Leukemia and Lymphoma (NCT03829540)Huda Salman2020-07-09

Track Huda Salman automatically

Every clearance here is in the API, with alerts when new ones post.